Mitroflow DL Post Approval Study- North America
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 186 participants.
Also called NCT02351726
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 186 participants
- Sponsor
- Registry
-
NCT02351726
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT02351726. Allocation not applicable; no masking; primary purpose treatment. Start 2015-03 (actual); primary completion 2019-12-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Mitroflow DL Post Approval Study- North America
- Condition
- Aortic Stenosis
- Condition
- Aortic Regurgitation
- Condition
- Aortic Valve Insufficiency
- Condition
- Heart Valve Diseases
- Condition
- Cardiovascular Abnormalities
- Condition
- Cardiovascular Diseases
- Condition
- Congenital Abnormalities
- Condition
- Heart Diseases
- Condition
- Pathological Conditions, Anatomical
- Intervention (Device)
- Mitroflow DL
- Lead sponsor
- LivaNova
Record details
- Record id
cardio:ct-nct02351726- Content hash
60dbbce3a36b0f58714652761d95f6c49e44d0acccd9100990dd1d0d8ce9bc16